US 8343998
Triazolothiadiazole inhibitor of c-Met protein kinase
granted A61PA61P11/00A61P35/00
Quick answer
US patent 8343998 (Triazolothiadiazole inhibitor of c-Met protein kinase) held by Vertex Pharmaceuticals Incorporated expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61P, A61P11/00, A61P35/00, A61P35/04, A61P43/00